UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition Sporanox-100mg-Cap-SE-IS-MPD
identifier: http://ema.europa.eu/fhir/mpId
/SE-100003163-00011900, http://ema.europa.eu/fhir/eurdId
/1798
domain: Human use
status: Current
combinedPharmaceuticalDoseForm: Capsule, hard
indication:
Candidavaginit. Direktmikroskopi- och/eller odlingsverifierade svampinfektioner i hud och naglar, då systembehandling anses nödvändig. Invasiv aspergillos. Officiella riktlinjer för korrekt användning av antimykotika ska beaktas.
legalStatusOfSupply: Medicinal product subject to medical prescription
classification: J02AC02
name
productName: Sporanox 100 mg Kapsel, hård
part
part: Sporanox
type: Invented name part
part
part: 100 mg
type: Strength part
part
part: Kapsel, hård
type: Pharmaceutical dose form part
Usages
Country Language Kingdom of Sweden Swedish